expression genes Mkrn3 decreased pro gressively puberty adult ages Conclusions Different types lossoffunction MKRN3 mutations associated premature sexual development sexes Their phenotypes relatively uniform regardless mutation type Clinical features children MKRN3 mutations similar idiopathic CPP group Adrenal ADRENAL CASE REPORTS I An Adrenal Incidentaloma Extramedullary Hematopoiesis Tyler Zachary MD1 Lillian Lien MD2 1University Mississippi Medical Center Jackson MS USA 2UMMC Ridgeland MS USA SAT208 Introduction Adrenal adenomas incidentally noted nonadrenal disease imaging rate 4 Frequency incidentalomas increases age adrenocortical adenomas This case highlights uncommon etiology adrenal mass finding Case Description A 37yearold history hypertension hypothyroidism tobacco use admitted postoperative complication Prior sur gery experiencing right upper quadrant pain 70 lb weight loss diarrhea She frequent palpitations Patient undergone cholecystec tomy common hepatic duct injury noted Imaging vealed 53 x 35 cm right adrenal mass previously unknown prior surgery Hormonal workup negative overpro duction aldosterone cortisol DHEAS metanephrines Discussion Patient underwent successful resection adrenal mass revealing adrenal adenoma osseous metaplasia hematopoiesis Extramedullary hematopoiesis usu ally discovered incidentally case Typical sites spleen liver Cases adrenal gland manifestations reported presence hemoglobinopathies thalassemia hereditary spherocytosis myelofibrosis At fourmonth followup laboratory testing patient didnt suggest erythrocytic leukocytic disorder Conclusion This case highlights uncommon finding hematopoiesis adrenal incidentaloma underlying hema tologic defect disease References Motta I Boiocchi L Delbini P Migone De Amicis M Cassinerio E Dondossola D Rossi G Cappellini M D 2016 A giant adrenal myelolipoma betathalassemia major patient Does effective erythropoiesis play role Am J Hematol 91 12811282 doi101002ajh24446 Stewart P NewellPrice J 2016 The Adrenal Cortex In Melmed S Polonsky K Larsen P Kronenberg H Williams Textbook Endocrinology 13th ed pp 489555 Philadelphia PA Elsevier doi 101210jendsobvaa046 Journal Endocrine Society A699 McGovern Medical School The University Texas Health Science Center Houston Houston TX United States Houston TX USA MON902 Background Intravenous etomidate infusion non hypnotic doses rapidly lowers cortisol levels blocking 11beta hydroxylation deoxycortisol inhibit cortisol production It underutilized drug concerns excess sedation ICU monitoring Clinical Case 1 A 44 yearold female HTN diabetes recently diagnosed pancreatic neuroendocrine tumor liver metastases presented altered mentation Labs showed severe hypokalemia metabolic alkalosis serum AM cortisol 602 ugdL n 67226 ugdL ACTH 6981 pgmL n 72 633 pgmL 24hour urine free cortisol UFC 5791 ug24hr n 564 ug24hr midnight salivary cortisol 804 ugdL n 001009 abnormal low dose LDDST high dose HDDST dexamethasone suppression tests cortisol 602 ugdL She developed worsening psychosis likely sec ondary hypercortisolism After ICU transfer etomidate fusion initiated 25 mghr titrated upward leading rapid drop cortisol levels concomitant improvement mentation No respiratory airway difficulties developed Ketoconazole metyrapone started etomidate weaned Steroids added cortisol levels fell 10 ugdL block replace The patient eventually underwent bilateral adrenalectomy improve ment hemodynamic blood glucose parameters She discharged physiologic replacement doses hydrocortisone fludrocortisone reported issues months later Clinical Case 2 A 51 yearold man month hematochezia presented hypertension severe hypoka lemia metabolic alkalosis QTc prolongation Colonoscopy unremarkable labs revealed cortisol 431 ugdL ACTH 836 pgmL 24hour UFC 7494 ugL abnormally elevated LDDST Imaging showed pan creatic mass multiple hypodense liver lesions The overall presentation suggestive ectopic ACTH syndrome metastatic neuroendocrine carcinoma confirmed biopsy Chemotherapy ketoconazole metyrapone adequately lowered cortisol Etomidate drip initiated 3 mghr ICU rapid reduction cortisol levels 20 ugdL respiratory compromise Attempts wean etomidate unsuccessful patient underwent bilateral adrenalectomy The surgery compromised extensive liver pancreatic enlargement follow imaging revealed incomplete resection 8am cortisol level etomidate 600 ugdL Metyrapone ketoconazole resumed hydrocortisone later initiated block replace The patient remains critical condition Conclusion Etomidatein non hypnotic doses useful rapid lowering cortisol levels Tumor Biology ENDOCRINE NEOPLASIA CASE REPORTS II Etomidate Under Utilized Safe Efficacious Drug Treat Acute Severe Cushings Syndrome Case Reports Ectopic ACTH Syndrome Neuroendocrine Malignancies Elena Thampy Cherian MBBS Sapna Naik MD Marc Cillo MD Neel L Shah MD Absalon Dennis Gutierrez MD Katie Guttenberg MD Philip R Orlander MD Diabetes Mellitus Glucose Metabolism DIABETES TECHNOLOGY AND ADVANCES IN CLINICAL TRIALS Racial Differences Technology Use Among Type 1 Diabetes SafetyNet Hospital Kamonkiat Wirunsawanya MD Ivania Rizo MD Kathryn Fantasia MD Boston University Medical Center Boston MA USA A699 JESOCI Volume 4 Abstract Supplement 2020